Skip to Main Content
ADVERTISEMENT
SCROLL TO CONTINUE WITH CONTENT



Property Value
Status
Version
Ad File
Disable Ads Flag
Environment
Moat Init
Moat Ready
Contextual Ready
Contextual URL
Contextual Initial Segments
Contextual Used Segments
AdUnit
SubAdUnit
Custom Targeting
Ad Events
Invalid Ad Sizes
Advertisement
Journal of Investigative Dermatology Home
Close
  • Home
  • Articles & Issues
    • Back
    • Articles In Press
    • Current Issue
    • List of Issues
    • Meeting Abstracts
    • Supplements
  • Authors
    • Back
    • About Open Access
    • Submit a Manuscript 
    • Welcome, Authors!
    • Information for Authors
    • Information for Authors - PDF Download 
    • Contact the Editorial Office
    • Permissions
  • Reviewers
    • Back
    • Information for Reviewers
    • Reviewer Login 
  • Journal Info
    • Back
    • About the Journal
    • About Open Access
    • Contact the Editorial Office
    • Editorial Board
    • Abstracting/Indexing
    • Access Instructions
    • New Content Alerts
    • Submit a Manuscript 
    • Why Publish in JID?
  • Collections
    • Back
    • Atopic Dermatitis
    • Cover Gallery
    • Itch
    • JAAD / JID Junction
    • Landmarks in Cutaneous Biology
    • Melanoma
    • Methods and Techniques for Skin Research
    • Montagna Symposium on the Biology of Skin
    • Pemphigus and Pemphigoid
    • Progress in Translational Research
    • Psoriasis
    • Resources for Clinical Research in the JID
  • News
    • Back
    • Society/Journal News
  • Advertisers 
  • SID
    • Back
    • SID Member Activation 
    • SID Website 
    • Join SID 
    • Annual Meeting 
    • Academic Industry Partnership 
  • ESDR
    • Back
    • ESDR Website 
    • Join ESDR 
    • Awards 
    • Events 
    • Media 
    • Education 
  • JAAD / JID Junction
  • Companion Titles
    • Back
    • Journal of Investigative Dermatology Symposium Proceedings
    • JID Innovations
Advanced searchSave search

Please enter a term before submitting your search.

Ok
  • Submit
  • Log in
  • Register
  • Log in
    • Submit
    • Log in
  • Subscribe
  • Claim
Skip menu
    x

    Filter:

    Filters applied

    • Melanoma
    • qRT-PCRRemove qRT-PCR filter
    Clear all

    Article Type

    • Research Article7

    Publication Date

    Author

    • Arscott, Guyan1
    • Bastonini, Emanuela1
    • Bayat, Ardeshir1
    • Birlea, Smaranda I1
    • Birlea, Stanca A1
    • Boniface, Katia1
    • Cota, Carlo1
    • Dai, Wei1
    • Das, Soumen1
    • Dell'Anna, Maria Lucia1
    • Farshchian, Mehdi1
    • Fujita, Mayumi1
    • Gao, Bifeng1
    • Gao, Tianwen1
    • Ge, Rui1
    • Goldstein, Nathaniel B1
    • Guo, Sen1
    • Han, Xianlin1
    • Har-Shai, Yaron1
    • Hoaglin, Laura G1
    • Hodgkinson, Tom1
    • Jones, Kenneth L1
    • Jumper, Natalie1
    • Kallajoki, Markku1
    • Kim, Ji-Ae1

    Journal

    • Journal of Investigative Dermatology7

    Keyword

    • FC2
    • NHEK2
    • RNA-seq2
    • ROS2
    • siRNA2
    • small interfering RNA2
    • 3,4-dihydro-5-[4-(1-piperidinyl) butoxy]-1(2H)-isoquinolinone1
    • AK1
    • AKR1B101
    • ALDH1
    • CNP1
    • CRABP1
    • CYP261
    • DEG1
    • Dickkopf11
    • DKK11
    • DPQ1
    • DUSP1
    • ECM1
    • ERK1
    • ET-11
    • F-LCM1
    • HDF1
    • HF1

    Access Filter

    • Open Access

    Melanoma

    7 Results
    Subscribe to collection
    • Export
      • PDF
      • Citation

    Please select at least one article in order to proceed.

    Ok
    FilterHide Filter
    • Original Article Melanocytes/Melanoma
      Open Archive

      Repigmentation of Human Vitiligo Skin by NBUVB Is Controlled by Transcription of GLI1 and Activation of the β-Catenin Pathway in the Hair Follicle Bulge Stem Cells

      Journal of Investigative Dermatology
      Vol. 138Issue 3p657–668Published online: October 17, 2017
      • Nathaniel B. Goldstein
      • Maranke I. Koster
      • Kenneth L. Jones
      • Bifeng Gao
      • Laura G. Hoaglin
      • Steven E. Robinson
      • and others
      Cited in Scopus: 26
      • Preview Hide Preview
      • Download PDF
      • Export Citation
        Vitiligo repigmentation is a complex process in which the melanocyte-depleted interfollicular epidermis is repopulated by melanocyte precursors from hair follicle bulge that proliferate, migrate, and differentiate into mature melanocytes on their way to the epidermis. The strongest stimulus for vitiligo repigmentation is narrow-band UVB (NBUVB), but how the hair follicle melanocyte precursors are activated by UV light has not been extensively studied. To better understand this process, we developed an application that combined laser capture microdissection and subsequent whole transcriptome RNA sequencing of hair follicle bulge melanocyte precursors and compared their gene signatures to that of regenerated mature epidermal melanocytes from NBUVB-treated vitiligo skin.
        Repigmentation of Human Vitiligo Skin by NBUVB Is Controlled by Transcription of GLI1 and Activation of the β-Catenin Pathway in the Hair Follicle Bulge Stem Cells
      • Original Article Melanocytes/Melanoma
        Open Archive

        Vitiligo Skin: Exploring the Dermal Compartment

        Journal of Investigative Dermatology
        Vol. 138Issue 2p394–404Published online: October 9, 2017
        • Daniela Kovacs
        • Emanuela Bastonini
        • Monica Ottaviani
        • Carlo Cota
        • Emilia Migliano
        • Maria Lucia Dell’Anna
        • and others
        Cited in Scopus: 38
        • Preview Hide Preview
        • Download PDF
        • Export Citation
          There is an increasing interest in the apparently normal skin in vitiligo. Altered expression of the adhesion molecule E-cadherin and persistent deregulated intracellular redox status that promotes the acquisition of a stress-induced senescent phenotype in melanocytes of normally pigmented skin from patients with vitiligo have been described. Growing evidence has shown that such cellular and functional alterations are not necessarily restricted to melanocytes but may be extended to other cutaneous cell populations in both lesional and nonlesional areas.
          Vitiligo Skin: Exploring the Dermal Compartment
        • Original Article Immunology/Infection
          Open Archive

          STING Is Involved in Antiviral Immune Response against VZV Infection via the Induction of Type I and III IFN Pathways

          Journal of Investigative Dermatology
          Vol. 137Issue 10p2101–2109Published online: June 21, 2017
          • Ji-Ae Kim
          • Seul-Ki Park
          • Seong-Wook Seo
          • Chan-Hee Lee
          • Ok Sarah Shin
          Cited in Scopus: 36
          • Preview Hide Preview
          • Download PDF
          • Export Citation
            Varicella zoster virus (VZV) is a human-restricted α-herpesvirus that exhibits tropism for the skin. The VZV host receptors and downstream signaling pathways responsible for the antiviral innate immune response in the skin are not completely understood. Here, we show that STING mediates an important host defense against VZV infection in dermal cells including human dermal fibroblasts and HaCaT keratinocytes. Inhibition of STING using small interfering-RNA or short hairpin RNA-mediated gene disruption resulted in enhanced viral replication but diminished IRF3 phosphorylation and induction of IFNs and proinflammatory cytokines.
            STING Is Involved in Antiviral Immune Response against VZV Infection via the Induction of Type I and III IFN Pathways
          • Original Article Melanocytes/Melanoma
            Open Archive

            MicroRNA-211 Regulates Oxidative Phosphorylation and Energy Metabolism in Human Vitiligo

            Journal of Investigative Dermatology
            Vol. 137Issue 9p1965–1974Published online: May 11, 2017
            • Anupama Sahoo
            • Bongyong Lee
            • Katia Boniface
            • Julien Seneschal
            • Sanjaya K. Sahoo
            • Tatsuya Seki
            • and others
            Cited in Scopus: 50
            • Preview Hide Preview
            • Download PDF
            • Export Citation
              Vitiligo is a common chronic skin disorder characterized by loss of epidermal melanocytes and progressive depigmentation. Vitiligo has complex immune, genetic, environmental, and biochemical causes, but the exact molecular mechanisms of vitiligo development and progression, particularly those related to metabolic control, are poorly understood. In this study we characterized the human vitiligo cell line PIG3V and the normal human melanocyte line HEM-l by RNA sequencing, targeted metabolomics, and shotgun lipidomics.
              MicroRNA-211 Regulates Oxidative Phosphorylation and Energy Metabolism in Human Vitiligo
            • Original Article Tumor Biology
              Open Access

              Long Noncoding RNA PICSAR Promotes Growth of Cutaneous Squamous Cell Carcinoma by Regulating ERK1/2 Activity

              Journal of Investigative Dermatology
              Vol. 136Issue 8p1701–1710Published online: April 2, 2016
              • Minna Piipponen
              • Liisa Nissinen
              • Mehdi Farshchian
              • Pilvi Riihilä
              • Atte Kivisaari
              • Markku Kallajoki
              • and others
              Cited in Scopus: 51
              • Preview Hide Preview
              • Download PDF
              • Export Citation
                Keratinocyte-derived cutaneous squamous cell carcinoma (cSCC) is the most common metastatic skin cancer, and its incidence is increasing globally. Long noncoding RNAs (lncRNA) are involved in various biological processes, and their role in cancer progression is emerging. Whole transcriptome analysis of cSCC cells (n = 8) and normal human epidermal keratinocytes (n = 4) revealed overexpression of long intergenic ncRNA (LINC00162) in cSCC cells. The expression of LINC00162 in cSCC cells was upregulated by inhibition of the p38α and p38δ mitogen-activated protein kinases.
                Long Noncoding RNA PICSAR Promotes Growth of Cutaneous Squamous Cell Carcinoma by Regulating ERK1/2 Activity
              • Original Article Wound Healing
                Open Archive

                The Aldo-Keto Reductase AKR1B10 Is Up-Regulated in Keloid Epidermis, Implicating Retinoic Acid Pathway Dysregulation in the Pathogenesis of Keloid Disease

                Journal of Investigative Dermatology
                Vol. 136Issue 7p1500–1512Published online: March 26, 2016
                • Natalie Jumper
                • Tom Hodgkinson
                • Guyan Arscott
                • Yaron Har-Shai
                • Ralf Paus
                • Ardeshir Bayat
                Cited in Scopus: 17
                • Preview Hide Preview
                • Download PDF
                • Export Citation
                  Keloid disease is a recurrent fibroproliferative cutaneous tumor of unknown pathogenesis for which clinical management remains unsatisfactory. To obtain new insights into hitherto underappreciated aspects of keloid pathobiology, we took a laser capture microdissection-based, whole-genome microarray analysis approach to identify distinct keloid disease-associated gene expression patterns within defined keloid regions. Identification of the aldo-keto reductase enzyme AKR1B10 as highly up-regulated in keloid epidermis suggested that an imbalance of retinoic acid metabolism is likely associated with keloid disease.
                  The Aldo-Keto Reductase AKR1B10 Is Up-Regulated in Keloid Epidermis, Implicating Retinoic Acid Pathway Dysregulation in the Pathogenesis of Keloid Disease
                • Original Article Melanocytes/Melanoma
                  Open Archive

                  Xeroderma Pigmentosum Group A Promotes Autophagy to Facilitate Cisplatin Resistance in Melanoma Cells through the Activation of PARP1

                  Journal of Investigative Dermatology
                  Vol. 136Issue 6p1219–1228Published online: February 12, 2016
                  • Rui Ge
                  • Lin Liu
                  • Wei Dai
                  • Weigang Zhang
                  • Yuqi Yang
                  • Huina Wang
                  • and others
                  Cited in Scopus: 25
                  • Preview Hide Preview
                  • Download PDF
                  • Export Citation
                    Xeroderma pigmentosum group A (XPA), a key protein in the nucleotide excision repair pathway, has been shown to promote the resistance of tumor cells to chemotherapeutic drugs by facilitating the DNA repair process. However, the role of XPA in the resistance of melanoma to platinum-based drugs like cisplatin is largely unknown. In this study, we initially found that XPA was expressed at higher levels in cisplatin-resistant melanoma cells than in cisplatin-sensitive ones. Furthermore, the knockdown of XPA not only increased cellular apoptosis but also inhibited cisplatin-induced autophagy, which rendered the melanoma cells more sensitive to cisplatin.
                    Xeroderma Pigmentosum Group A Promotes Autophagy to Facilitate Cisplatin Resistance in Melanoma Cells through the Activation of PARP1
                  Page 1 of 1

                  Login to your account

                  Show
                  Forgot password?
                  Don’t have an account?
                  Create a Free Account

                  If you don't remember your password, you can reset it by entering your email address and clicking the Reset Password button. You will then receive an email that contains a secure link for resetting your password

                  If the address matches a valid account an email will be sent to __email__ with instructions for resetting your password

                  Cancel
                  • Home
                  • Articles & Issues
                  • Articles In Press
                  • Current Issue
                  • List of Issues
                  • Meeting Abstracts
                  • Supplements
                  • Authors
                  • About Open Access
                  • Submit a Manuscript
                  • Welcome, Authors!
                  • Information for Authors
                  • Information for Authors - PDF Download
                  • Contact
                  • Permissions
                  • Reviewers
                  • Information for Reviewers
                  • Reviewer Login
                  • Journal Info
                  • About the Journal
                  • About Open Access
                  • Contact the Editorial Office
                  • Editorial Board
                  • Abstracting/Indexing
                  • Access Instructions
                  • New Content Alerts
                  • Submit a Manuscript
                  • Why Publish in JID?
                  • Collections
                  • Atopic Dermatitis
                  • Cover Gallery
                  • Itch
                  • JAAD / JID Junction
                  • Landmarks in Cutaneous Biology
                  • Melanoma
                  • Methods and Techniques for Skin Research
                  • Montagna Symposium on the Biology of Skin
                  • Pemphigus & Pemphigoid
                  • Progress in Translational Research
                  • Psoriasis
                  • Resources for Clinical Research in the JID
                  • News
                  • Society/Journal News
                  • Advertisers
                  • SID
                  • SID Member Activation
                  • SID Website
                  • Join SID
                  • Annual Meeting
                  • Academic Industry Partnership
                  • ESDR
                  • ESDR Website
                  • Join ESDR
                  • Awards
                  • Events
                  • Media
                  • Education
                  • JAAD / JID Junction - NEW!
                  • Companion Titles
                  • Journal of Investigative Dermatology Symposium Proceedings
                  • JID Innovations
                  • Follow Us
                  • Facebook
                  • Twitter

                  The content on this site is intended for healthcare professionals.



                  We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the Cookie Preference Center for this site.
                  Copyright © 2023 Elsevier Inc. except certain content provided by third parties.

                  • Privacy Policy  
                  • Terms and Conditions  
                  • Accessibility  
                  • Help & Contact

                  RELX